St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart ...(s most comprehensive heart and vascular ...),Health

Date:7/8/2009

s most comprehensive heart and vascular services. The commitment of our physicians to the prevention and cure of heart disease has led to innovative care, better outcomes and improved quality of life for patients. St. Francis created the Emergency Heart Attack Response Team (EHART) protocol, which has revolutionized heart attack treatment in the United States and abroad. St. Francis has the only 24/7 comprehensive heart center in south central Indiana, providing everything from angioplasty to heart valve repair. For more information, go to www.stfrancishospitals.org/heart.

About St. Francis Hospital & Health Centers

St. Francis Hospital & Health Centers has three main hospitals in Indianapolis, Beech Grove and Mooresville and operates a medical office building in Plainfield. St. Francis Hospital is part of a network of 13 growing hospital campuses in Indiana and Illinois owned and operated by the Mishawaka-based Sisters of St. Francis Health Services Inc., one of the largest health care systems in Indiana. For more information, go to www.stfrancishospitals.org.

About CorMatrix(R) ECM Technology(TM)

CorMatrix Cardiovascular holds an exclusive license from Purdue University to research, develop, manufacture and market naturally occurring ECM(TM) products for cardiovascular applications. The company currently has U.S. clearance and European approval with a CE Mark for its ECM Technology as an implant for pericardial closure, and clearance in the U.S. for use in cardiac tissue repair. For more information, visit www.cormatrix.com.

'/>"/>

SOURCE St. Francis Heart Center Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
2. TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients
3. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
4. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
5. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
6. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
7. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
8. Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
9. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
10. NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs
11. Surgeon Generals Call to Action to Prevent DVT/PE Praised by NATT as Turning Point